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Abstract
Diabetic foot ulcers (DFUs) lead to nearly 100,000 lower limb amputations annually in the
United States. DFUs are colonized by complex microbial communities, and infection is one
of the most common reasons for diabetes-related hospitalizations and amputations. In this
study, we examined how DFU microbiomes respond to initial sharp debridement and off-
loading and how the initial composition associates with 4 week healing outcomes. We
employed 16S rRNA next generation sequencing to perform microbial profiling on 50 sam-
ples collected from 10 patients with vascularized neuropathic DFUs. Debrided wound sam-
ples were obtained at initial visit and after one week from two DFU locations, wound bed and
wound edge. Samples of the foot skin outside of the wounds were also collected for compar-
ison. We showed that DFU wound beds are colonized by a greater number of distinct bacte-
rial phylotypes compared to the wound edge or skin outside the wound. However, no
significant microbiome diversity changes occurred at the wound sites after one week of stan-
dard care. Finally, increased initial abundance of Gram-positive anaerobic cocci (GPAC),
especially Peptoniphilus (p < 0.05; n = 5 subjects), was associated with impaired healing;
thus, GPAC’s abundance could be a predictor of the wound-healing outcome.
Introduction
Diabetes mellitus (DM) affects over 422 million people worldwide and nearly 30 million
Americans [1–3]. Diabetic foot ulcers (DFUs) are chronic wounds that develop upon skin
injury in patients with long-standing and often poorly-controlled DM. DFUs occur in up to
25% of all patients with DM [4, 5], and even with standard care, one in three DFUs fails to heal
[1, 2, 6, 7] preceding 85% of all diabetes-related lower-leg amputations [8]. DFU patients are
highly susceptible to rapidly spreading infection that can lead to soft tissue damage and osteo-
myelitis, lower limb amputation (approximately 100,000 cases annually in the USA), sepsis,
and death [1, 2, 6, 7].
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DFUs are colonized by microorganisms, and bacteria are routinely isolated from DFUs by
standard culturing methods. However, these methods fail to identify many bacterial species
colonizing DFUs because these species grow poorly or cannot be cultured in the laboratory
[9]. High-throughput DNA sequencing methods permit a culture-independent examination of
the bacterial composition with extraordinary depth [10, 11]. In fact, 16S rRNA sequencing-
based microbial profiling detects many more complex wound microbiota than described pre-
viously using culture-based analyses.[12, 13] Multiple DFU microbiome studies have reported
diverse microbiota in DFUs with Staphylococcus, Streptococcus, Corynebacterium, and many
obligate anaerobes being the most prevalent [12–14]. Additionally, both pathogenic and com-
mensal bacterial species were observed in DFUs [15]. A well-designed study by Gardner et al.
demonstrated an association between DFU microbiomes and clinical factors such as ulcer
depth, duration, and poor glycemic control [14]. However, it wasn’t until recently that a
longitudinal study of DFU’s microbiomes described the temporal dynamics of microbial
composition throughout the course of DFU management [16]. The most recent data from
metagenomic sequencing shows that specific strains of S. aureus are associated with impaired
wound healing, suggesting the importance of S. aureus strain variations in clinical outcomes
[17].
Currently, the standard care for DFUs includes sharp debridement and offloading using a
removable boot or, occasionally, a contact cast to relieve pressure in the affected foot [5, 18].
Even with quality standard care, more than 30% of patients with DFUs fail to heal, resulting in
lower limb amputations [5, 19, 20]. Furthermore, antibiotic therapy has not shown to improve
healing of non-infected DFUs [21–23]. Debridement provides clinical benefits through the
removal of unresponsive and necrotic tissue [5, 24]. This process is repeated weekly to stimu-
late wound repair and enhance healing.[25] Current research is beginning to examine the tem-
poral dynamics of wound microbiota [16, 17, 26, 27]; however, the extent to which initial
debridement affects the DFU microbiota is still unclear.
In this study, we addressed if one week of standard care alters DFU microbiome composi-
tion and if the initial composition associates with 4 week healing outcomes. We collected
debrided specimens from 10 patients with vascularized neuropathic DFUs at initial visit and at
a follow-up one week later, and performed 16S rRNA microbiome profiling using next genera-
tion sequencing. We compared the changes in the diversity, abundance, and taxonomic com-
position of DFU microbiota following one week of standard care. Finally, we addressed the
hypothesis that there might be an association between healing outcome and the DFU micro-
biome’s initial composition.
Materials and methods
Patients and samples
The patient demographics and clinical parameters are presented in Table 1 and S1 Table. This
study was approved by the University of Miami Miller School of Medicine Institutional Review
Board (CR00001542). Specimens of human skin were obtained from patients with DM and
plantar DFU. A total of 10 patients were enrolled and provided standard DFU treatment for 4
weeks which included baseline wound debridement and offloading. Wound size was measured
weekly for 4 weeks and healing, as measured by percentage of wound-size reduction, was
assessed after 4 weeks of standard care.
Inclusion criteria included the following: 21 years of age or older; vascularized plantar neu-
ropathic DFU with duration of at least 4 weeks and larger than 0.5 cm2; and compliance with
the use of off-loading diabetic boot. Subjects were excluded from the study for having any of
the following criteria: use of topical or systemic antibiotics over the course of 2 weeks prior to
DFU microbiome
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debridement; active cellulitis or osteomyelitis; vascular insufficiency; ankle–brachial index
lower than 0.7 or higher than 1.3; revascularization to the ipsilateral lower extremity in the last
6 weeks; history of immunodeficiency or neoplastic lesions in ulcer area; or use of experimen-
tal treatments or drugs in the last 4 weeks. The level of glycemic control was measured as
hemoglobin HbA1c values [28, 29].
There were equal numbers of men and women enrolled (Table 1). Eight patients had type-2
DM and 2 type-1 DM. Hemoglobin A1c for the patients were between 5.7 and 8.7, except for
one patient (10.1). Patients received standard care with off-loading removable diabetic boot
for the entire study, removed only at weekly study visits. During the first and second study vis-
its, ulcer tissue samples and swabs of the foot skin outside the wound were collected. The
ulcers were then covered with foam dressing. Ulcer size measurements and photographs were
collected weekly for 4 weeks. Wound duration was measured as the number of weeks from the
time of soft tissue loss to the baseline visit obtained through subject report and review of medi-
cal records.
Ulcer healing
As a surrogate endpoint for complete healing, we used the well-established 50% wound size
reduction after 4 weeks [30, 31]. Wounds that were� 50% closed by week 4 were defined as
“healing wounds”; all other wounds were defined as “non-healing wounds”. Ulcer size, includ-
ing surface area and depth, was measured using planimetry. Ulcer size measurements were
done pre- and post-debridement weekly for the duration of the study.
Sample collection
Skin swabs were collected before cleansing from the medial, plantar part of the foot, 2.5 cm
away from the wound dressing. Skin swabs were obtained using the Levine technique [32]
weekly in the first 2 weeks of the study. The swab was moistened in sterile PBS and rotated
over a 1 cm2 area of the foot skin for 5 seconds using sufficient pressure. Swabs were taken
from the foot skin without occlusion. A total of 20 skin swabs were collected.
Ulcer specimens were obtained before cleansing by debridement of the wound edge (skin
immediately adjacent to the wound bed) using a scalpel and debridement of the entire wound
bed with a curette at patients’ initial visit and at a follow-up visit one week later. A total of 20
wound-bed and 20 wound-edge samples were collected. Special care was taken not to cross-
contaminate samples during the collection.
All specimens were submerged in PBS-based collection fluid (MoBio), placed at -80˚C
within one hour from collection and stored until DNA isolation.
Table 1. Patient demographics and clinical parameters.
Parameters Healing Wounds Non-Healing Wounds
Patients 5 5
Sex 2 Males, 3 Females 3 Males, 2 Females
Median Age 73 56
Diabetes Type All type II 3 type II, 2 type I
Median Ulcer Duration (months) 4 8
Antibiotic therapy None None
HbA1c (± SD) 7.3 ± 1.3 7.4 ± 1.6
ABI (± SD) 1.114 ± 0.201 1.092 ± 0.074
https://doi.org/10.1371/journal.pone.0227006.t001
DFU microbiome
PLOS ONE | https://doi.org/10.1371/journal.pone.0227006 January 24, 2020 3 / 20
Afterwards, ulcers that needed debridement underwent further debridement without tissue
collection. Hemostasis was achieved with local pressure or, only if necessary, with topical
hemostatic agents (Aluminum chloride 20%) or electrocautery at the discretion of the
surgeon.
DNA isolation
DNA was isolated from tissue samples with the ZR Fungal/Bacterial DNA Mini Prep™ kit
(Zymo Research, Irvine, CA) according to manufacturer’s protocol and optimized for high-
throughput processing. Cell lysis was carried out with approximately 30–40 mg of DFU tissue
samples using 1 ml of sterile zirconia beads containing an equal mixture of 0.1 mm and 0.5
mm beads. Bead-beating was carried out in a FastPrep-24™ homogenizer (MP Biomedicals,
Santa Ana, CA) at 4.5 m/s for 60 seconds with 1 min cooling on ice in between for a total num-
ber of 4 cycles. All samples were quantified via the Qubit1 / Quant-iT dsDNA High Sensitivity
Kit (Invitrogen, Life Technologies, Carlsbad, CA). A total of 60 samples were processed
(S1 Table). Twenty wound bed, twenty wound edge, and ten adjacent skin samples yielded suf-
ficient 16S rDNA for sequencing. Sample collection controls were also processed but 16S
rDNA was not detected in the controls; thus, they were not sequenced.
Library preparation and sequencing
Library preparation and sequencing was carried out by Second Genome, Inc. (San Francisco,
CA). To enrich the samples for bacterial V4 region of the 16S RNA gene, DNA was PCR
amplified in 25 μl reactions using 10 ng of template DNA with 5Prime HotMasterMix (Quan-
tabio, Beverly, MA) and 5 pmol of primers 515F (5’-GTG CCA GCM GCC GCG GTA
A-3’) and 806R (5’-GGA CTA CHV GGG TWT CTA AT-3’). Thermocycling consisted
of an initial denaturation step at 94˚C for 3 min, followed by 25 cycles of denaturation at 94˚C
for 45 sec, annealing at 50˚C for 60 sec, and extension at 72˚C for 90 sec, and a final extension
step at 72˚C for 10 min. The barcodes were attached to the indexed reverse primers. Following
amplification of bacterial V4 target sequences, PCR products were purified using the Agen-
court AMPure XP clean-up kit according to manufacturer’s protocol (Beckman Coulter, Brea,
CA). Amplicons were then quantified using the Quant-iT PicoGreen dsDNA Assay Kit as per
manufacturer’s instructions (Thermo-Fisher Scientific, Waltham, MA). Equimolar amounts of
all sample amplicons were pooled into a single multiplexed library and the quality and molar-
ity of the resulting library were assessed using a BioAnalyzer High Sensitivity DNA chip (Agi-
lent Technologies, Santa Clara, CA). Barcoded samples were loaded into a MiSeq1 reagent
cartridge, and then onto the instrument (Illumina MiSeq). The samples were sequenced for
250 cycles with custom primers designed for paired-end sequencing. Negative controls for the
library preparations and sequencing included samples in which molecular grade water was
used instead of DNA template. A known mixture of “mock” microbiome sample was included
as a positive control.
The sequencing data has been deposited to the NCBI Sequence Read Archive database
(accession number PRJNA579196).
OTU selection
Sequenced paired-end reads were merged, quality filtered, and de-replicated with USEARCH
[33]. Resulting unique sequences were then clustered at 97% similarity by UPARSE (de novo
OTU clustering) and a representative consensus sequence per de novo OTU was determined.
The clustering algorithm also performed filtering to discard likely chimeric OTUs. Sequences
that passed quality filtering were then mapped to a set of representative consensus sequences
DFU microbiome
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to generate an OTU abundance table. Representative OTU sequences were assigned taxo-
nomic classification via mothur’s Bayesian classifier at 80% confidence; the classifier was
trained against the Greengenes reference database [34] of 16S rRNA gene sequences clustered
at 99%. After the taxa were identified for inclusion in the analysis, the values used for each
taxa-sample intersection were populated with the abundance of reads assigned to each OTU.
The data was normalized by calculating relative OTU abundance (S2 Table).
Data analysis and statistical tests
Bacterial diversity and community analyses were performed using the R statistical computing
language [35] ver 3.4.3 and the package vegan [36] ver 2.4.6. Alpha-diversity metrics were
assessed using the functions specnumber for sample richness determination and diversity for
Shannon-Weaver diversity indices. Pielou’s evenness was calculated as a ratio of the Shannon
diversity index over the log of richness. For calculations of the alpha diversity metrics, we used
non-rarified relative abundance values. Statistical significance testing was carried out using a
one-way analysis of variance (ANOVA) followed by post-hoc analysis using Tukey’s honest
significant difference test (HSD).
Beta-diversity metrics were assessed using the vegan function metaMDS to generate a
community dissimilarity distance matrix for ordination using a non-metric multidimensional
scaling approach. For significance testing of factors and interactions that affect bacterial com-
positions, a permutational multivariate analysis (PERMANOVA) was carried out using the
function adonis on the Bray-Curtis dissimilarity matrix.
For statistical significance testing of taxonomic composition, analysis of composition of
microbiomes (ANCOM)[37] was performed using the R package ancom.R ver 1.1.3 and scikit-
bio 0.5.0. Only the wound bed and wound edge samples were analyzed for significance testing
of the relative abundance at the phylum and genus levels.
Power analysis was performed using the R package micropower [38].
Results
Microbiome profiling of DFUs
To investigate how the initial debridement influences the composition of wound microbiota,
we profiled the microbiome of DFU samples collected from patients at initial visit and at fol-
low-up after one week. Specifically, tissue samples were collected by debridement from wound
edge and wound bed, and swabs from the foot skin outside the wound. Total DNA was isolated
from all samples (n = 60). However, we could not detect any DNA in 10 skin-swab samples
(S1 Table) and these samples were not sequenced.
Microbial profiling was performed using the V4 conserved regions of bacterial 16S rRNA
with Illumina MiSeq Next Generation Sequencing. A summary of the sequencing information
is presented in Table 2. Sequencing resulted in excess of 16 million total raw reads. Merging of
paired reads and quality filtering resulted in ~6.4 million reads. More then 6.1 million reads
were assigned taxonomic identification. After de-replication, clustering and taxonomic assign-
ment, we detected 1,478 total de novo operational taxonomic units (OTUs). We performed
independent filtering to remove OTUs that were spurious (i.e. OTUs that were not seen at
least once within 10% of the dataset) which resulted in 563 OTUs. We also removed contami-
nating OTUs that were found in the negative controls for library preparation. These filtering
processes decreased the OTU number to 525 and the resulting OTUs were used in all subse-
quent analyses.
The sample library size was normally distributed around the mean and standard deviation
of 145,987 ± 60,617 (Table 2). We did not observe any significant differences in sample library
DFU microbiome
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sizes due to the different sample collection techniques (tissue debridement versus swabs, t-test
p = 0.459).
Impact of clinical covariates on DFU microbiota
The significance of clinical covariates on DFU wound bed and wound edge microbiota were
assessed using PERMANOVA, and their impact on beta-diversity using the Bray-Curtis dis-
similarity is presented in a NMDS ordination (stress = 0.21) (S1 Fig). Analysis of clinical covar-
iates yielded statistical significance for individual subject (‘Patient ID’), sampling location
(‘Location’), healing outcome (‘Outcome’), Diabetes Type (‘Diabetes’), HbA1C, ABI, Gender,
Age, and wound duration (‘Duration’) (S1 Fig). Among these, HbA1C, Gender and Patient ID
contributed to the greatest difference in microbiota. Given the limited number of subjects
enrolled in this study, the individual subject microbiota differences appear to underlie these
confounding clinical covariates.
No statistically significant correlations could be made between the metadata and wound
healing outcome.
Bacterial diversity in DFUs
We compared the alpha diversity indices such as richness, Shannon-Weaver diversity, and Pie-
lou’s evenness to evaluate the differences in the bacterial diversity of DFUs. The sample rich-
ness represents the number of unique taxa found regardless of abundance. The Shannon-
Weaver diversity index, on the other hand, represents a measure of the distribution of all taxa
based on their abundance. A higher Shannon-Weaver index indicates the presence of a greater
number of substantial taxa. Pielou’s evenness provides a measure of dominance in a commu-
nity with a maximum value of 1 representing equal abundance by all taxa and a minimum
value of 0 representing dominance by a single taxon. The results of alpha diversity analysis are
presented in Fig 1 based on 1) sampling location and 2) time of patient visit. Overall, we found
that the wound bed samples were colonized by a significantly greater number of mean unique
taxa (204) compared to foot skin (149) or wound edge (150) samples (ANOVA F(2,47) =
9.583, p< 0.001). Taking into consideration the relative abundance of each taxon, no signifi-
cant differences in Shannon-Weaver diversity (p = 0.281) or Pielou’s evenness (p = 0.647) were
observed. When we compared the bacterial diversity in DFUs at initial visit and one week
later, no significant differences were observed in the bacterial alpha diversity indices (2-Way
ANOVA Location x Time p> 0.7) (Fig 1).
Table 2. Sequencing summary.
Total reads 16,389,328
Total reads paired 8,107,765
Total filtered reads 6,412,740
Total reads matched to raw OTUs 6,131,576
Total reads matched to filtered OTUs 6,131,200
Library size (Mean ± SD) 145,987 ± 60,617
Average read length 251
Average length of paired reads 252
Total de novo raw OTUs 1,577
Total de novo filtered OTUs 1,478
Total OTUs after independent filtering 563
Total OTUs after removal of contaminating OTUs 525
https://doi.org/10.1371/journal.pone.0227006.t002
DFU microbiome
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Analysis of dissimilarities in the composition of DFU microbiota
To determine the differences in the composition of DFU microbiome between wound bed,
wound edge, and foot skin, at initial visit and one week after administration of standard DFU
care, we performed beta diversity analysis by calculating a pair-wise dissimilarity matrix of the
relative abundance for all OTUs in the samples collected using the Bray-Curtis dissimilarity.
This index quantifies the differences in both, composition and abundance of biological com-
munities along a gradient or across distinct sites with a maximum value of 1 representing no
shared taxa and a minimum value of 0 representing total similarity. The resulting matrix dis-
similarities were rank ordered and ordination was carried out using the non-metric multidi-
mensional scaling. The results presented in Fig 2 showed the distribution of each sample’s
compositional dissimilarity across two non-metric dimensions. The more dissimilar the
Fig 1. Bacterial diversity based on sampling location and time point. The alpha diversity indices showing sample
richness (richness), Shannon-Weaver diversity (diversity) and Pielou’s evenness (evenness) are presented based on
sampling location and time point. Healthy Skin–swabs outside of wound area, Wound Bed–debrided tissue from a
wound base, Wound Edge–debrided peripheral tissue surrounding a wound.
https://doi.org/10.1371/journal.pone.0227006.g001
DFU microbiome
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composition is between the samples, the further they are located relative to one another. The
results showed no distinct separation of wound microbiota based on sampling location (Fig
2A) or one week of standard DFUs’ care (Fig 2B). All the DFU sample clusters overlapped with
one another and indicated that their bacterial compositions shared a large degree of similarity.
To address the extent to which these DFU microbiota differed, we performed a follow-up com-
munity membership analysis to determine the distribution of unique OTUs across the differ-
ent sampling locations regardless of abundance. This was carried out using the presence and
absence criteria as described by Shade and Handelsman [39]. The result of this analysis is pre-
sented as a Venn diagram in Fig 3 and corroborates the findings of the ordination in Fig 2A.
Among all OTUs analyzed in this study (525), we found that almost 80% (419) of OTUs were
shared between the DFU samples. Twenty OTUs were only present in wound bed samples, 73
Fig 2. Bray-Curtis based ordination of DFU microbiomes (β-diversity). Non-metric multidimensional scaling
(NMDS) plot (goodness of fit or stress = 0.21) showing the compositional dissimilarities of all samples collected in this
study according to (A) sampling location and (B) time point (DFU care). Ellipsoids represent a 95% confidence
interval used to group each sample.
https://doi.org/10.1371/journal.pone.0227006.g002
DFU microbiome
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were shared between wound bed and wound edge samples, and 12 were shared between
wound bed and foot skin. No unique OTUs were found in the foot skin samples.
Taxonomic composition of DFU microbiome
Analysis of taxonomic composition revealed that the microbiota of DFUs comprise an average
of 172 ± 50 phylotypes per sample based on presence/absence. However, an average of 14 ± 6
OTUs among these had a relative abundance greater than 0.5% and indicated that only
approximately 8% of all OTUs make up the bulk of the microbial communities while the rest
are present in fractional abundance. When we examined the taxonomic identities of OTUs,
their classifications span across 13 different phyla, 92 families, and 142 genera (Table 3). An
assessment of the mean relative abundance in collected samples provided an overview of the
dominant taxa (Fig 4). On average, the microbiome of foot skin and DFUs comprised of five
dominant phyla that included Firmicutes (44.7%), Actinobacteria (35.1%), Proteobacteria
(14.5%), Bacteroidetes (4.6%) and Fusobacteria (0.9%). The remaining 8 phyla were not abun-
dant and collectively comprised less than 0.2% of all OTUs. Some differences in the taxonomic
composition at the phylum level were observed for the different sampling locations (Fig 4).
The relative abundance of Fusobacteria (pink) was negligible in foot skin; Firmicutes (green)
Fig 3. Community membership analysis. A 3-way Venn diagram showing unique and shared taxa between samples
from different locations. Selection criteria was based on presence or absence regardless of abundance. Not drawn to
scale.
https://doi.org/10.1371/journal.pone.0227006.g003
DFU microbiome
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were more abundant in wound edge tissue samples; and Proteobacteria (purple) were more
abundant in wound bed tissue samples; however, these differences were not statistically signifi-
cant (p> 0.05). When we examined the microbial composition at the phylum level in wound
edge and wound bed tissue samples collected at initial visit versus one week later, we did not
observe statistically significant changes (p> 0.05). At lower taxonomic ranks, further assess-
ment of the mean relative abundance revealed that of the 92 families present in DFU samples,
26 were dominant (Fig 5A) while 28 out of 142 genera were dominant (Fig 5B). The most
abundant families included Staphylococcaceae (21.1%), Corynebacteriaceae (20.2%), Clostri-
diales Incertae Sedis XI (12.5%), Alcaligenaeceae (8.3%), Micrococcaceae (7.1%), Brevibacteria-
ceae (6.0%), and Peptoniphilaceae (4.7%). Substantial genera included Staphylococcus (21.1%),
Corynebacterium (20.3%), Arthrobacter (6.9%), Finegoldia (6.1%), Brevibacterium (6.0%), Pep-
toniphilus (4.7%), Oligella (4.7%), Anaerococcus (3.9%), Alcaligenes (3.4%), Streptococcus
(2.7%), Porphyromonas (1.7%) and Pseudomonas (1.0%).
Table 3. Unique identified taxa.
Rank Number
Kingdom 1
Phylum 13
Class 28
Order 46
Family 92
Genus 142
https://doi.org/10.1371/journal.pone.0227006.t003
Fig 4. Microbiome composition of DFU samples. Pie charts showing the relative abundance and composition of the most dominant phyla
according to sampling location and time point.
https://doi.org/10.1371/journal.pone.0227006.g004
DFU microbiome
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Impact of the initial DFU microbiome’s composition on healing outcome
We compared alpha diversity of the DFU microbiomes in the samples collected at the initial
visit, grouping the samples based on the assessment of healing outcome. For the wound bed
samples, the results showed no statistically significant differences in sample richness, Shan-
non-Weaver diversity, or community evenness (p> 0.05, Fig 6A). Similar results were
observed for wound edge samples (p> 0.05, Fig 6B). Analysis of compositional dissimilarities
based on the ordination of Bray-Curtis also showed no distinct separation of DFU samples
(Fig 6C), indicating that the microbiota composition of DFUs that healed compared to those
that did not heal shared a large degree of similarity.
We also examined the distribution of microbial abundance at the phylum level in wound
bed and wound edge samples taken at both time points. In initial samples from DFUs that
later showed impaired healing, we observed an increased abundance of Firmicutes, Bacteroi-
detes, and Fusobacteria, and a reduction of Actinobacteria compared to the healing DFUs
(Fig 7); however, these differences were not statistically significant (p> 0.05). In contrast, we
observed statistically significant abundance increase of the genus Peptoniphilus (p< 0.05)
based on the frequency of occurrence and mean abundance of dominant taxa (� 5%) in the
wound bed and wound edge samples of the DFUs with impaired healing (n = 5 subjects;
n = 20 samples per group) (Table 4, Figs 6C and 8). We also observed an increase in abundance
of Finegoldia, Anaerococcus, and Helcococcus in the same samples (Table 4, Figs 6C and 8).
Although this increase was not statistically significant (p> 0.05), we had 70% power to detect
significant differences for Finegoldia and Anaerococcus in our samples (n = 5 subjects; n = 20
samples per group).
Additionally, we have performed a power analysis looking at comparisons between healing
and non-healing wounds for initial wound edge or wound bed samples. We assume, based on
data reported here, that 3% of OTUs are unique to either group and the average number of
reads per OTU is approximately 250. We would need 30 subjects per group to have at least
Fig 5. Mean relative abundance of bacterial families and genera in DFU microbiomes. Stacked bar plots showing the
composition of the most dominant (A) families and (B) genera color-coded in order of phylum and ranked according to
abundance. A relative abundance greater than 0.5% was considered abundant in this analysis. Pink, Fusobacteria; Blue,
Bacteroidetes; Purple: Proteobacteria; Orange, Actinobacteria; Green, Firmicutes.
https://doi.org/10.1371/journal.pone.0227006.g005
DFU microbiome
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Fig 6. Bacterial diversity in healing and non-healing DFU microbiomes. Diversity of the DFU microbiomes was
compared in the samples collected at the initial visit, grouping the samples based on the healing outcome. The alpha
diversity indices showing sample richness (richness), Shannon-Weaver diversity (diversity) and Pielou’s evenness
(evenness) are presented based on healing outcome for (A) wound bed and (B) wound edge samples. (C) The
compositional dissimilarity in the microbiome of healing and non-healing wounds is presented as a non-metric
multidimensional scaling (NMDS) plot (goodness of fit or stress = 0.21) based on the ordination of Bray-Curtis
dissimilarity (β-diversity). Direction and length of arrows indicate which GPAC contributed to the microbiota
compositions of wounds that healed (Arthrobacter and Corynebacterium) or did not heal (Peptoniphilus, Anaerococcus,
Finegoldia, and Helcococcus).
https://doi.org/10.1371/journal.pone.0227006.g006
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Fig 7. Impact of initial DFU microbiome composition on healing outcome. Pie charts showing the distribution of the most dominant
phyla according to healing outcome, sampling location, and time point.
https://doi.org/10.1371/journal.pone.0227006.g007
Table 4. Mean relative abundance of dominant taxa (� 5%) in wound samples of healing and non-healing DFUs.
Genera / Species Phylum Healing (n = 20) Non-Healing (n = 20)
n Mean Abundance (%) n Mean Abundance (%)
Staphylococcus Firmicutes 12 34.46 (± 24.33) 11 34.58 (± 21.29)
Finegoldia magna Firmicutes 2 29.00 (± 4.26) 14 13.55 (± 6.90)
Anaerococcus Firmicutes 5 7.31 (± 2.92) 7 13.31 (± 9.17)
Peptoniphilus gorbachii Firmicutes 2 6.37 (± 0.04) 10 8.90 (± 4.38)
Enterococcus Firmicutes 1 6.12 1 17.59
Streptococcus agalactiae Firmicutes 6 16.53 (± 9.42) - -
Peptostreptococcus anaerobius Firmicutes 3 13.94 (± 5.28) - -
Helcococcus Firmicutes - - 2 7.60 (± 1.95)
Helcococcus kunzii Firmicutes - - 1 10.41
Corynebacterium Actinobacteria 19 21.93 (± 12.03) 14 22.13 (± 10.20)
Arthrobacter cumminsii Actinobacteria 4 36.66 (± 9.07) 1 12.09
Arthrobacter Actinobacteria 4 8.53 (± 1.97) 1 5.31
Brevibacterium luteolum Actinobacteria 2 17.42 (± 9.56) 2 44.19 (± 0.56)
Actinomyces europaeus Actinobacteria 2 6.12 (± 1.58) 1 5.1
Brevibacterium Actinobacteria 4 11.95 (± 3.73) - -
Corynebacterium aurimucosum Actinobacteria 2 17.66 (± 1.42) - -
Corynebacterium tuberculostearicum Actinobacteria 1 17.25 - -
Actinomyces neuii Actinobacteria 1 7.14 - -
Oligella urethralis Proteobacteria 4 14.13 (± 8.77) 4 18.60 (± 7.34)
Alcaligenes spp. Proteobacteria 5 14.71 (± 8.13) 1 7.34
Pseudomonas aeruginosa Proteobacteria 2 21.58 (± 1.37) - -
Morganella morganii Proteobacteria - - 2 10.26 (± 0.06)
Campylobacter Proteobacteria - - 1 8.54
Porphyromonas Bacteroidetes 3 14.84 (± 4.67) 4 8.02 (± 2.46)
Bacteroides fragilis Bacteroidetes - - 2 11.97 (± 6.09)
Fusobacterium Fusobacteria - - 4 11.19 (± 3.76)
https://doi.org/10.1371/journal.pone.0227006.t004
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80% (initial wound edge) power or 70% (initial wound bed) power to detect any significant dif-
ference at the OTU level between groups at adjusted p<0.05.
The increased abundance of Peptoniphilus, Finegoldia, Anaerococcus, and Helcococcus, all
classified as Gram-positive anaerobic cocci (GPAC), contributed to the increase of Firmicutes
in non-healing DFUs (Fig 7). On the other hand, there was a reduced abundance of Arthrobac-
ter and Corynebacterium (Figs 6C and 8, Table 4), which contributed to the decrease in abun-
dance of Actinobacteria in non-healing DFUs (Fig 7). However, these changes were not
statistically significant.
Discussion
Microbial profiling of DFUs using 16S rRNA sequencing shows the existence of a heteroge-
neous community of microorganisms, even in the absence of any overt clinical signs of infec-
tion [10, 12, 14, 15]. Several studies have addressed longitudinal changes in the chronic wound
microbiome as well as associations between the microbiota and clinical outcomes during the
course of treatment, such as debridement and/or antibiotic therapy [16, 17, 26, 27]. However,
all these studies addressed bi-weekly or variable treatment regimens. In contrast, weekly treat-
ment’s impact on the wound microbiota is still poorly understood. An understanding of the
early temporal changes occurring in microbial composition is important to improve current
wound management practices.
In this study, we used 16S rRNA next generation sequencing to examine the compositional
changes occurring in the microbiota of DFUs at the patients’ initial visit and one week later to
assess the impact of initial standard treatment. Furthermore, we addressed the possibility that
the initial DFU microbiome composition could be a prognostic biomarker of healing/non-
healing.
Our data showed that the bacterial diversity in DFUs differed between wound and foot
skin. Specifically, we showed that DFU wound beds are colonized by a greater number of dis-
tinct bacterial phylotypes compared to the wound edge or skin outside the wound at both
time points. To our knowledge, this is the first study that showed the difference between
Fig 8. Stacked bar plots showing the composition of predominant genera in healing and non-healing (A) wound bed or (B) wound edge samples
before and after standard care. A relative abundance greater than 0.5% was considered in this analysis.
https://doi.org/10.1371/journal.pone.0227006.g008
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microbiomes in these three locations. A previous study that addressed spatial variation of
chronic wound microbiota reported minimal differences at different locations only within
individual wound beds [40].
Analysis of clinical covariates on DFU microbiota showed significance for sampling loca-
tion, healing outcome, diabetes type, HbA1C, ABI, Gender and Age. Given the limited number
of subjects enrolled in this study, the individual subject microbiota appeared to underlie these
confounding clinical variables.
Analyses of the OTUs present in the wound bed samples showed that approximately 80% of
the bacterial taxa are the resident microbiota of the foot based on their shared presence in the
foot skin outside the wound. The other 20% of the taxa found in the wound bed were com-
mensal microbiota, pathogenic microbiota, and several environmental bacterial species, which
is not surprising given that these wounds are exposed to the environment. For example, we
detected environmental species of Arthrobacter, such as A. cumminsii, in DFUs. It has been
previously shown that Arthrobacter species are sometimes present in skin infections [41–43],
including DFUs [44–46].
The results of our taxonomic analysis showed that 5 out of 13 phyla were predominantly
abundant, making up over 99% of the DFU microbiota. These dominant phyla were Firmi-
cutes, Actinobacteria, Proteobacteria, Bacteroidetes, and Fusobacteria, consistent with pub-
lished studies [14, 26, 47]. There were some differences in the proportion of each phylum
compared to the published data, which may be attributed to the patient demographics, differ-
ent sampling techniques, inclusion of control (foot skin outside the wound) and the sequenc-
ing targets (V1-V3 vs V4). We found that, out of 142 genera, 12 were predominant in DFUs.
While the majority of these predominant genera, notably Staphylococcus, Corynebacterium,
and Finegoldia, were in good agreement with the published literature [12, 14, 15, 26, 45, 47],
we found a surprisingly low abundance of Pseudomonas in our samples. Low abundance of
Pseudomonas was also observed by Malone et al. [47] and may be attributed to differences in
patient demographics and environmental factors [12, 15, 45].
A technical limitation in this study prevented the detection of genus Cutibacterium
(formerly Propionibacterium), which is a prominent commensal found on the human skin.
Specifically, we were not able to detect Cutibacterium because we sequenced the V4 hypervar-
iable region of 16S rRNA [48]. A study by Nelson et al. suggested that the absence of P. acnes
in V4 libraries might be attributed to a single nucleotide mismatch in the 16S rRNA gene of
P. acnes that prevents annealing of the 515F primer [49]. Nevertheless, studies of chronic
wounds targeting the different 16S rRNA hypervariable regions sensitive for Cutibacterium
have reported low frequency of occurrence and abundance of this genus in diabetic foot
ulcers [12, 15, 16, 45].
Of interest to future studies, we found a substantial presence of Brevibacterium, Oligella,
and Alcaligenes that has not been reported previously. Although their contribution to DFU
pathogenesis remains unknown, these three bacterial genera have often been implicated in
other clinical infections and should be considered in future studies [50–53].
When we examined the impact of initial debridement on DFUs’ microbiota, we found that
the bacterial diversities at the first visit and one week follow-up visit were similar. This is in
agreement with the studies by Tipton et al. showing that the microbiome communities are
more similar within a short time-period [27]. These results also indicate that the DFU micro-
biota might not have been completely removed by the initial sharp debridement and recolo-
nized the wound within a week, which is consistent with clinical observations that multiple
cycles of wound debridement and offloading are necessary to observe even partial wound
closures.
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When we grouped the wound samples based on the surrogate-healing outcome, we
observed that initial abundance of anaerobic bacteria, specifically GPAC (including Peptoni-
philus, Anaerococcus, Finegoldia, and Helcococcus), in DFU microbiome might be associated
with impaired healing. Specifically, we found a statistically significant increase in frequency of
occurrence and relative abundance of the genus Peptoniphilus. We have also observed increase
of Anaerococcus, Finegoldia, and Helcococcus, but this increase was not statistically significant.
Based on power analyses, we would need 30 subjects per group to detect any significant differ-
ence between healing and non-healing wounds, thus our data should be confirmed on a larger
group of subjects.
Sloan et al. also reported the presence of anaerobic bacteria, including Gram-positive anaer-
obes, in 20 non-healing DFUs and speculated that DFU microbiomes are determined by the
ulcer environment and that consistent presence of certain combinations of bacteria may con-
tribute to delayed healing [26].
GPAC are both resident bacteria of the human skin and opportunistic pathogens present in
DFUs that are deep, necrotic, and ischemic [54–56]. Studies have shown that GPAC express
multiple virulence factors which can trigger inflammation and enhance survival against anti-
bacterial peptides, resulting in increased pathogenicity and impaired wound healing [56].
Although more studies are needed to address this question, it is possible that the abundance of
GPAC, especially Peptoniphilus, could be used as a predictor of wound healing. Kalan et al.
also proposed that the microbiome could serve as a prognostic marker of impaired healing
based on the observation that mean proportion of several anaerobic genera such as Anaerococ-
cus, Helcococcus, Porphyromonas, Prevotella, and Veillonella did not change in unhealed DFUs
at 12 weeks post-debridement [17]. In contrast, the same genera were significantly reduced
after debridement in DFUs that healed within the same time period. However, the authors did
not explain why debridement only affects abundance of anaerobic bacteria in healing wounds.
As noted above, what our data shows is that the baseline abundance of several anaerobic gen-
era is higher in non-healing as compared to healing wounds. Perhaps when deep layers of
ulcers are in fact colonized by anaerobic bacteria such as GPAC, even sharp debridement
could not remove these anaerobes from non-healing ulcers. Additionally, the host response
could be impaired and incapable of combating these anaerobes in non-healing DFUs.
We have also observed a decreased abundance of Arthrobacter and Corynebacterium. A bio-
logical explanation as to why a reduction in these genera coincided with impaired DFUs
remains unclear at present. It is possible that some of the species belonging to these genera
produce antimicrobial agents (such as bacteriocins) that prevent proliferation of pathogenic
bacteria, thus having a beneficial role in DFU healing.
Conclusions
We have observed substantial bacterial diversity and abundance in DFUs that was not signifi-
cantly altered after one week of standard care. We also found that the bacterial diversity in
DFUs differed between wound and foot skin outside the wound at both time points. Our data
also revealed an association between a higher abundance of GPAC, especially Peptoniphilus,
and impaired DFU healing. Thus, abundance of this genus could be used as a predictor of
DFU healing.
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